Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases

por Pilzweger, Christin, Holdenrieder, Stefan
Publicado 2015

Cell-Free Nucleic Acids: Physico-Chemical Properties, Analytical Considerations, and Clinical Applications

por Bronkhorst, Abel J., Holdenrieder, Stefan
Publicado 2023

The emerging role of cell-free DNA as a molecular marker for cancer management

por Bronkhorst, Abel Jacobus, Ungerer, Vida, Holdenrieder, Stefan
Publicado 2019

The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies

por Gezer, Ugur, Bronkhorst, Abel J., Holdenrieder, Stefan
Publicado 2022

The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients

por Gezer, Ugur, Bronkhorst, Abel J., Holdenrieder, Stefan
Publicado 2022

Clinically Meaningful Use of Blood Tumor Markers in Oncology

por Holdenrieder, Stefan, Pagliaro, Lance, Morgenstern, David, Dayyani, Farshid
Publicado 2016

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes

por Ndrepepa, Gjin, Holdenrieder, Stefan, Bernlochner, Isabell, Kastrati, Adnan
Publicado 2021

Histone Modifications in Stem Cell Development and Their Clinical Implications

por Völker-Albert, Moritz, Bronkhorst, Abel, Holdenrieder, Stefan, Imhof, Axel
Publicado 2020

Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line

por Ungerer, Vida, Bronkhorst, Abel J., Uhlig, Carsten, Holdenrieder, Stefan
Publicado 2022

Longitudinal Evaluation of AFP and CEA External Proficiency Testing Reveals Need for Method Harmonization

por Wojtalewicz, Nathalie, Vierbaum, Laura, Kaufmann, Anne, Schellenberg, Ingo, Holdenrieder, Stefan
Publicado 2023

Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells

por Gezer, Ugur, Tiryakioglu, Duygu, Bilgin, Elif, Dalay, Nejat, Holdenrieder, Stefan
Publicado 2015

Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures

por Oberhofer, Angela, Bronkhorst, Abel J., Uhlig, Carsten, Ungerer, Vida, Holdenrieder, Stefan
Publicado 2022

Isolation and Quantification of Plasma Cell-Free DNA Using Different Manual and Automated Methods

por Polatoglou, Eleni, Mayer, Zsuzsanna, Ungerer, Vida, Bronkhorst, Abel J., Holdenrieder, Stefan
Publicado 2022

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

por Kohles, Nikolaus, Nagel, Dorothea, Jüngst, Dietrich, Durner, Jürgen, Stieber, Petra, Holdenrieder, Stefan
Publicado 2011

Immune checkpoint therapy for pancreatic cancer

por Johansson, Henrik, Andersson, Roland, Bauden, Monika, Hammes, Sarah, Holdenrieder, Stefan, Ansari, Daniel
Publicado 2016

Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis

por Holdenrieder, Stefan, Wehnl, Birgit, Hettwer, Karina, Simon, Kirsten, Uhlig, Steffen, Dayyani, Farshid
Publicado 2017

Acute metabolic effects of tonic‐clonic seizures

por Nass, Robert D., Zur, Berndt, Elger, Christian E., Holdenrieder, Stefan, Surges, Rainer
Publicado 2019

High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood

por Krueger, Kimberly, Mayer, Zsuzsanna, Gerckens, Miriam, Boeck, Stefan, Luppa, Peter, Holdenrieder, Stefan
Publicado 2022

The coffee ingredients caffeic acid and caffeic acid phenylethyl ester protect against irinotecan‐induced leukopenia and oxidative stress response

por Kalthoff, Sandra, Paulusch, Stefan, Rupp, Alexander, Holdenrieder, Stefan, Hartmann, Gunther, Strassburg, Christian P.
Publicado 2020

Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures

por Ungerer, Vida, Bronkhorst, Abel J., Van den Ackerveken, Priscilla, Herzog, Marielle, Holdenrieder, Stefan
Publicado 2021